Novel motif:117: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 15:10, 9 September 2013
name: | motif117_SKSNGCGCTSN |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0007195 | inhibition of adenylate cyclase activity by dopamine receptor signaling pathway | 6.786705e-9 |
GO:0043503 | skeletal muscle fiber adaptation | 1.645276e-8 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 5.019044e-8 |
GO:0006768 | biotin metabolic process | 8.404805e-8 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 1.522595e-7 |
GO:0035470 | positive regulation of vascular wound healing | 2.476867e-7 |
GO:0009440 | cyanate catabolic process | 9.379166e-7 |
GO:0008033 | tRNA processing | 1.156828e-6 |
GO:0015878 | biotin transport | 1.331868e-6 |
GO:0015887 | pantothenate transmembrane transport | 1.331868e-6 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 2.021992e-6 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 2.039557e-6 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 3.161718e-6 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 3.182567e-6 |
GO:0060038 | cardiac muscle cell proliferation | 3.349383e-6 |
GO:0006548 | histidine catabolic process | 4.883903e-6 |
GO:0050685 | positive regulation of mRNA processing | 5.244131e-6 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 5.555120e-6 |
GO:0032383 | regulation of intracellular cholesterol transport | 6.191724e-6 |
GO:0042136 | neurotransmitter biosynthetic process | 6.450758e-6 |
GO:0002002 | regulation of angiotensin levels in blood | 7.897887e-6 |
GO:0031468 | nuclear envelope reassembly | 8.089306e-6 |
GO:0055075 | potassium ion homeostasis | 9.238019e-6 |
GO:0006884 | cell volume homeostasis | 9.836570e-6 |
GO:0048102 | autophagic cell death | 9.962930e-6 |
GO:0006420 | arginyl-tRNA aminoacylation | 1.064954e-5 |
GO:0035461 | vitamin transmembrane transport | 1.233034e-5 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 1.320360e-5 |
GO:0006268 | DNA unwinding involved in replication | 1.578898e-5 |
GO:0060419 | heart growth | 1.891984e-5 |
GO:0009264 | deoxyribonucleotide catabolic process | 1.901196e-5 |
GO:0048050 | post-embryonic eye morphogenesis | 2.218397e-5 |
GO:0018352 | protein-pyridoxal-5-phosphate linkage | 2.292720e-5 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 2.469677e-5 |
GO:0031440 | regulation of mRNA 3'-end processing | 2.536818e-5 |
GO:0010225 | response to UV-C | 2.792563e-5 |
GO:0043089 | positive regulation of Cdc42 GTPase activity | 2.898100e-5 |
GO:0043097 | pyrimidine nucleoside salvage | 3.143770e-5 |
GO:0051586 | positive regulation of dopamine uptake | 3.405032e-5 |
GO:0070988 | demethylation | 4.279808e-5 |
GO:0051534 | negative regulation of NFAT protein import into nucleus | 4.283097e-5 |
GO:0010897 | negative regulation of triglyceride catabolic process | 4.587298e-5 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 4.587298e-5 |
GO:0016577 | histone demethylation | 4.593668e-5 |
GO:0010107 | potassium ion import | 5.097993e-5 |
GO:0035357 | peroxisome proliferator activated receptor signaling pathway | 5.739409e-5 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 5.870265e-5 |
GO:0060177 | regulation of angiotensin metabolic process | 5.899061e-5 |
GO:0006348 | chromatin silencing at telomere | 6.964059e-5 |
GO:0002071 | glandular epithelial cell maturation | 6.964059e-5 |
GO:0060999 | positive regulation of dendritic spine development | 7.312186e-5 |
GO:0055017 | cardiac muscle tissue growth | 8.906034e-5 |
GO:0050779 | RNA destabilization | 9.488761e-5 |
GO:0000724 | double-strand break repair via homologous recombination | 9.542175e-5 |
GO:0010984 | regulation of lipoprotein particle clearance | 1.033063e-4 |
GO:2000249 | regulation of actin cytoskeleton reorganization | 1.045644e-4 |
GO:0021568 | rhombomere 2 development | 1.152924e-4 |
GO:0032006 | regulation of TOR signaling cascade | 1.250712e-4 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 1.272170e-4 |
GO:0072337 | modified amino acid transport | 1.334305e-4 |
GO:0030539 | male genitalia development | 1.470506e-4 |
GO:0009304 | tRNA transcription | 1.522234e-4 |
GO:0010609 | posttranscriptional regulation of gene expression by mRNA localization | 1.522904e-4 |
GO:0061157 | mRNA destabilization | 1.522904e-4 |
GO:0002036 | regulation of L-glutamate transport | 1.560221e-4 |
GO:0048343 | paraxial mesodermal cell fate commitment | 1.600097e-4 |
GO:0001766 | membrane raft polarization | 1.601699e-4 |
GO:0007614 | short-term memory | 1.863058e-4 |
GO:0032862 | activation of Rho GTPase activity | 1.896885e-4 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 1.913483e-4 |
GO:0042420 | dopamine catabolic process | 1.938499e-4 |
GO:0031848 | protection from non-homologous end joining at telomere | 1.951112e-4 |
GO:0007379 | segment specification | 1.995164e-4 |
GO:0000725 | recombinational repair | 2.115556e-4 |
GO:0003326 | pancreatic A cell fate commitment | 2.161794e-4 |
GO:0003329 | pancreatic PP cell fate commitment | 2.161794e-4 |
GO:0001881 | receptor recycling | 2.170176e-4 |
GO:0070198 | protein localization to chromosome, telomeric region | 2.178836e-4 |
GO:0000731 | DNA synthesis involved in DNA repair | 2.205871e-4 |
GO:0071071 | regulation of phospholipid biosynthetic process | 2.226533e-4 |
GO:0022601 | menstrual cycle phase | 2.271488e-4 |
GO:0051764 | actin crosslink formation | 2.299341e-4 |
GO:0045005 | maintenance of fidelity involved in DNA-dependent DNA replication | 2.340984e-4 |
GO:0040015 | negative regulation of multicellular organism growth | 2.403575e-4 |
GO:0006482 | protein demethylation | 2.466053e-4 |
GO:0006540 | glutamate decarboxylation to succinate | 2.486651e-4 |
GO:0042424 | catecholamine catabolic process | 2.559010e-4 |
GO:2000786 | positive regulation of autophagic vacuole assembly | 2.596827e-4 |
GO:0071585 | detoxification of cadmium ion | 2.596827e-4 |
GO:0006778 | porphyrin-containing compound metabolic process | 2.834153e-4 |
GO:0072070 | loop of Henle development | 2.871402e-4 |
GO:0008272 | sulfate transport | 3.205815e-4 |
GO:0009451 | RNA modification | 3.243246e-4 |
GO:0034766 | negative regulation of ion transmembrane transport | 3.305143e-4 |
GO:0034723 | DNA replication-dependent nucleosome organization | 3.374492e-4 |
GO:0055026 | negative regulation of cardiac muscle tissue development | 3.374492e-4 |
GO:0071072 | negative regulation of phospholipid biosynthetic process | 3.448750e-4 |
GO:0045007 | depurination | 3.498614e-4 |
GO:0035356 | cellular triglyceride homeostasis | 3.498614e-4 |
GO:0030421 | defecation | 3.498614e-4 |
GO:0060430 | lung saccule development | 3.852040e-4 |
GO:0002357 | defense response to tumor cell | 3.853600e-4 |
GO:0045922 | negative regulation of fatty acid metabolic process | 3.880299e-4 |
GO:0007051 | spindle organization | 4.107491e-4 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 4.110167e-4 |
GO:0072086 | specification of loop of Henle identity | 4.111608e-4 |
GO:0071732 | cellular response to nitric oxide | 4.201713e-4 |
GO:0001946 | lymphangiogenesis | 4.332659e-4 |
GO:0006544 | glycine metabolic process | 4.821120e-4 |
GO:0031297 | replication fork processing | 5.125223e-4 |
GO:0051013 | microtubule severing | 5.196934e-4 |
GO:0070194 | synaptonemal complex disassembly | 5.219883e-4 |
GO:0044088 | regulation of vacuole organization | 5.219883e-4 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 5.219883e-4 |
GO:0045217 | cell-cell junction maintenance | 5.288544e-4 |
GO:0007288 | sperm axoneme assembly | 5.331109e-4 |
GO:0032312 | regulation of ARF GTPase activity | 5.439897e-4 |
GO:0006449 | regulation of translational termination | 5.679539e-4 |
GO:0006261 | DNA-dependent DNA replication | 5.884655e-4 |
GO:0048752 | semicircular canal morphogenesis | 5.982135e-4 |
GO:0006400 | tRNA modification | 6.111108e-4 |
GO:0051532 | regulation of NFAT protein import into nucleus | 6.671738e-4 |
GO:0006529 | asparagine biosynthetic process | 7.111688e-4 |
GO:0051181 | cofactor transport | 7.138749e-4 |
GO:0019264 | glycine biosynthetic process from serine | 7.227826e-4 |
GO:0090002 | establishment of protein localization in plasma membrane | 7.441672e-4 |
GO:0033013 | tetrapyrrole metabolic process | 7.560541e-4 |
GO:0000093 | mitotic telophase | 7.606177e-4 |
GO:0048561 | establishment of organ orientation | 7.678643e-4 |
GO:0015886 | heme transport | 7.750291e-4 |
GO:0045794 | negative regulation of cell volume | 7.910164e-4 |
GO:0006285 | base-excision repair, AP site formation | 7.972776e-4 |
GO:0042069 | regulation of catecholamine metabolic process | 8.950183e-4 |
GO:0032007 | negative regulation of TOR signaling cascade | 8.969008e-4 |
GO:0043088 | regulation of Cdc42 GTPase activity | 9.016631e-4 |
GO:0031936 | negative regulation of chromatin silencing | 9.025188e-4 |
GO:0031507 | heterochromatin formation | 9.296857e-4 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 9.403938e-4 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 9.824927e-4 |
GO:0030579 | ubiquitin-dependent SMAD protein catabolic process | 1.039055e-3 |
GO:0048627 | myoblast development | 1.086475e-3 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 1.102818e-3 |
GO:0043973 | histone H3-K4 acetylation | 1.102818e-3 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 1.102818e-3 |
GO:0006478 | peptidyl-tyrosine sulfation | 1.102818e-3 |
GO:0042417 | dopamine metabolic process | 1.112787e-3 |
GO:0032864 | activation of Cdc42 GTPase activity | 1.149051e-3 |
GO:0090398 | cellular senescence | 1.165228e-3 |
GO:0018993 | somatic sex determination | 1.191081e-3 |
GO:0010719 | negative regulation of epithelial to mesenchymal transition | 1.196699e-3 |
GO:0045945 | positive regulation of transcription from RNA polymerase III promoter | 1.197706e-3 |
GO:0090307 | spindle assembly involved in mitosis | 1.212448e-3 |
GO:0007182 | common-partner SMAD protein phosphorylation | 1.215182e-3 |
GO:0000413 | protein peptidyl-prolyl isomerization | 1.215538e-3 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 1.223476e-3 |
GO:0014888 | striated muscle adaptation | 1.238872e-3 |
GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin | 1.394915e-3 |
GO:0010735 | positive regulation of transcription via serum response element binding | 1.400065e-3 |
GO:0033002 | muscle cell proliferation | 1.451244e-3 |
GO:0010835 | regulation of protein ADP-ribosylation | 1.468991e-3 |
GO:0046684 | response to pyrethroid | 1.488747e-3 |
GO:0090281 | negative regulation of calcium ion import | 1.515238e-3 |
GO:0071584 | negative regulation of zinc ion import | 1.515238e-3 |
GO:0031627 | telomeric loop formation | 1.515238e-3 |
GO:0051324 | prophase | 1.626483e-3 |
GO:0090303 | positive regulation of wound healing | 1.691402e-3 |
GO:0060969 | negative regulation of gene silencing | 1.716744e-3 |
GO:0043174 | nucleoside salvage | 1.760325e-3 |
GO:0002523 | leukocyte migration involved in inflammatory response | 1.765604e-3 |
GO:0031118 | rRNA pseudouridine synthesis | 1.812085e-3 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 1.812085e-3 |
GO:0009155 | purine deoxyribonucleotide catabolic process | 1.856342e-3 |
GO:0032615 | interleukin-12 production | 1.859958e-3 |
GO:0031055 | chromatin remodeling at centromere | 1.874556e-3 |
GO:0070368 | positive regulation of hepatocyte differentiation | 1.894111e-3 |
GO:0046015 | regulation of transcription by glucose | 1.898767e-3 |
GO:0003360 | brainstem development | 1.915377e-3 |
GO:0045112 | integrin biosynthetic process | 1.952282e-3 |
GO:0042168 | heme metabolic process | 2.011926e-3 |
GO:0006760 | folic acid-containing compound metabolic process | 2.162298e-3 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 2.167662e-3 |
GO:0071104 | response to interleukin-9 | 2.233786e-3 |
GO:0042942 | D-serine transport | 2.233786e-3 |
GO:0002418 | immune response to tumor cell | 2.233786e-3 |
GO:0032863 | activation of Rac GTPase activity | 2.234669e-3 |
GO:0090344 | negative regulation of cell aging | 2.239346e-3 |
GO:0042133 | neurotransmitter metabolic process | 2.266482e-3 |
GO:0034776 | response to histamine | 2.297422e-3 |
GO:0071422 | succinate transmembrane transport | 2.297422e-3 |
GO:0007398 | ectoderm development | 2.303113e-3 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 2.321835e-3 |
GO:0045660 | positive regulation of neutrophil differentiation | 2.340964e-3 |
GO:0031365 | N-terminal protein amino acid modification | 2.416631e-3 |
GO:0071956 | cellular component maintenance at cellular level | 2.417268e-3 |
GO:0042506 | tyrosine phosphorylation of Stat5 protein | 2.438314e-3 |
GO:0007386 | compartment pattern specification | 2.495000e-3 |
GO:0043542 | endothelial cell migration | 2.507081e-3 |
GO:0042053 | regulation of dopamine metabolic process | 2.515293e-3 |
GO:0006244 | pyrimidine nucleotide catabolic process | 2.538481e-3 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 2.547579e-3 |
GO:0090141 | positive regulation of mitochondrial fission | 2.555478e-3 |
GO:0051590 | positive regulation of neurotransmitter transport | 2.559548e-3 |
GO:0070544 | histone H3-K36 demethylation | 2.577188e-3 |
GO:0031935 | regulation of chromatin silencing | 2.609095e-3 |
GO:0080111 | DNA demethylation | 2.609095e-3 |
GO:0031999 | negative regulation of fatty acid beta-oxidation | 2.649009e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 2.649009e-3 |
GO:0006391 | transcription initiation from mitochondrial promoter | 2.649009e-3 |
GO:0042538 | hyperosmotic salinity response | 2.672517e-3 |
GO:0045948 | positive regulation of translational initiation | 2.710542e-3 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 2.711054e-3 |
GO:0051645 | Golgi localization | 2.752627e-3 |
GO:0045064 | T-helper 2 cell differentiation | 2.752627e-3 |
GO:0002315 | marginal zone B cell differentiation | 2.752627e-3 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 2.775581e-3 |
GO:0033602 | negative regulation of dopamine secretion | 2.815452e-3 |
GO:0014034 | neural crest cell fate commitment | 2.818892e-3 |
GO:0070327 | thyroid hormone transport | 2.830661e-3 |
GO:0060580 | ventral spinal cord interneuron fate determination | 2.965297e-3 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 2.965297e-3 |
GO:0003327 | type B pancreatic cell fate commitment | 2.965297e-3 |
GO:0030903 | notochord development | 3.038644e-3 |
GO:0000072 | M phase specific microtubule process | 3.068995e-3 |
GO:0032319 | regulation of Rho GTPase activity | 3.123132e-3 |
GO:0003310 | pancreatic A cell differentiation | 3.189641e-3 |
GO:0042732 | D-xylose metabolic process | 3.191912e-3 |
GO:0002522 | leukocyte migration involved in immune response | 3.191912e-3 |
GO:0044070 | regulation of anion transport | 3.220437e-3 |
GO:0060160 | negative regulation of dopamine receptor signaling pathway | 3.244398e-3 |
GO:0006335 | DNA replication-dependent nucleosome assembly | 3.244398e-3 |
GO:0002003 | angiotensin maturation | 3.244398e-3 |
GO:0090342 | regulation of cell aging | 3.271390e-3 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 3.333643e-3 |
GO:0022027 | interkinetic nuclear migration | 3.405414e-3 |
GO:0070979 | protein K11-linked ubiquitination | 3.429502e-3 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 3.486364e-3 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 3.535278e-3 |
GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter | 3.556098e-3 |
GO:0009303 | rRNA transcription | 3.572062e-3 |
GO:0061014 | positive regulation of mRNA catabolic process | 3.600659e-3 |
GO:0006491 | N-glycan processing | 3.611897e-3 |
GO:0060017 | parathyroid gland development | 3.673448e-3 |
GO:0021871 | forebrain regionalization | 3.723085e-3 |
GO:0002921 | negative regulation of humoral immune response | 3.760661e-3 |
GO:0033604 | negative regulation of catecholamine secretion | 3.815003e-3 |
GO:0042703 | menstruation | 3.864760e-3 |
GO:0003406 | retinal pigment epithelium development | 3.864760e-3 |
GO:0019101 | female somatic sex determination | 3.864760e-3 |
GO:0021986 | habenula development | 3.910767e-3 |
GO:0045415 | negative regulation of interleukin-8 biosynthetic process | 3.984739e-3 |
GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 3.984739e-3 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 3.984739e-3 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 4.005633e-3 |
GO:0072610 | interleukin-12 secretion | 4.117701e-3 |
GO:0002408 | myeloid dendritic cell chemotaxis | 4.117701e-3 |
GO:0002074 | extraocular skeletal muscle development | 4.117701e-3 |
GO:0097151 | positive regulation of inhibitory postsynaptic membrane potential | 4.230832e-3 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 4.235667e-3 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 4.235815e-3 |
GO:0070309 | lens fiber cell morphogenesis | 4.251944e-3 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 4.326292e-3 |
GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter | 4.329511e-3 |
GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | 4.329511e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 4.463491e-3 |
GO:0071469 | cellular response to alkalinity | 4.465577e-3 |
GO:0031860 | telomeric 3' overhang formation | 4.465577e-3 |
GO:0071722 | detoxification of arsenic-containing substance | 4.465577e-3 |
GO:0019413 | acetate biosynthetic process | 4.465577e-3 |
GO:0019542 | propionate biosynthetic process | 4.465577e-3 |
GO:0031081 | nuclear pore distribution | 4.465577e-3 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 4.561966e-3 |
GO:0042309 | homoiothermy | 4.708885e-3 |
GO:0046333 | octopamine metabolic process | 4.708885e-3 |
GO:0051225 | spindle assembly | 4.742760e-3 |
GO:0070307 | lens fiber cell development | 4.766897e-3 |
GO:0018208 | peptidyl-proline modification | 4.788682e-3 |
GO:0010771 | negative regulation of cell morphogenesis involved in differentiation | 4.998306e-3 |
GO:2000077 | negative regulation of type B pancreatic cell development | 5.156547e-3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 5.156547e-3 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 5.259068e-3 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 5.259068e-3 |
GO:0034470 | ncRNA processing | 5.272550e-3 |
GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 5.396800e-3 |
GO:0050772 | positive regulation of axonogenesis | 5.420742e-3 |
GO:0006538 | glutamate catabolic process | 5.533302e-3 |
GO:0030327 | prenylated protein catabolic process | 5.626692e-3 |
GO:0060178 | regulation of exocyst localization | 5.626692e-3 |
GO:0001928 | regulation of exocyst assembly | 5.626692e-3 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 5.667824e-3 |
GO:0034969 | histone arginine methylation | 5.683938e-3 |
GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | 5.688778e-3 |
GO:0006281 | DNA repair | 5.811310e-3 |
GO:0035414 | negative regulation of catenin import into nucleus | 5.877360e-3 |
GO:0051935 | glutamate uptake involved in synaptic transmission | 5.927361e-3 |
GO:0006013 | mannose metabolic process | 5.942210e-3 |
GO:0051725 | protein de-ADP-ribosylation | 6.097341e-3 |
GO:0000022 | mitotic spindle elongation | 6.097341e-3 |
GO:0006515 | misfolded or incompletely synthesized protein catabolic process | 6.141211e-3 |
GO:0006419 | alanyl-tRNA aminoacylation | 6.294673e-3 |
GO:0032288 | myelin assembly | 6.300203e-3 |
GO:0016233 | telomere capping | 6.393833e-3 |
GO:0006447 | regulation of translational initiation by iron | 6.393833e-3 |
GO:0071218 | cellular response to misfolded protein | 6.427750e-3 |
GO:0042696 | menarche | 6.443491e-3 |
GO:0005997 | xylulose metabolic process | 6.443491e-3 |
GO:0002693 | positive regulation of cellular extravasation | 6.463929e-3 |
GO:0072061 | inner medullary collecting duct development | 6.549308e-3 |
GO:0097022 | lymphocyte migration into lymph node | 6.549308e-3 |
GO:0072060 | outer medullary collecting duct development | 6.549308e-3 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 6.549308e-3 |
GO:0009798 | axis specification | 6.579837e-3 |
GO:0010816 | calcitonin catabolic process | 6.598159e-3 |
GO:0034959 | endothelin maturation | 6.598159e-3 |
GO:0010814 | substance P catabolic process | 6.598159e-3 |
GO:0071316 | cellular response to nicotine | 6.601396e-3 |
GO:0035419 | activation of MAPK activity involved in innate immune response | 6.617259e-3 |
GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly | 6.617259e-3 |
GO:0051882 | mitochondrial depolarization | 6.635171e-3 |
GO:0060286 | flagellar cell motility | 6.635171e-3 |
GO:0043622 | cortical microtubule organization | 6.635171e-3 |
GO:0030103 | vasopressin secretion | 6.635171e-3 |
GO:0045065 | cytotoxic T cell differentiation | 6.638861e-3 |
GO:0021796 | cerebral cortex regionalization | 6.638861e-3 |
GO:0016140 | O-glycoside metabolic process | 6.647276e-3 |
GO:0061205 | paramesonephric duct development | 6.657975e-3 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 6.657975e-3 |
GO:0060242 | contact inhibition | 6.657975e-3 |
GO:0034198 | cellular response to amino acid starvation | 6.657975e-3 |
GO:0030953 | astral microtubule organization | 6.812665e-3 |
GO:0000389 | nuclear mRNA 3'-splice site recognition | 6.812665e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 6.885635e-3 |
GO:0015816 | glycine transport | 6.912870e-3 |
GO:0021892 | cerebral cortex GABAergic interneuron differentiation | 6.960311e-3 |
GO:0045994 | positive regulation of translational initiation by iron | 7.464846e-3 |
GO:0000076 | DNA replication checkpoint | 7.464846e-3 |
GO:0002037 | negative regulation of L-glutamate transport | 7.464846e-3 |
GO:0001522 | pseudouridine synthesis | 7.512571e-3 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 7.519352e-3 |
GO:0060976 | coronary vasculature development | 7.555088e-3 |
GO:0043985 | histone H4-R3 methylation | 7.686661e-3 |
GO:0006547 | histidine metabolic process | 7.731451e-3 |
GO:0045820 | negative regulation of glycolysis | 7.829805e-3 |
GO:0007020 | microtubule nucleation | 7.871836e-3 |
GO:0072081 | specification of nephron tubule identity | 7.909586e-3 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 7.938407e-3 |
GO:0009069 | serine family amino acid metabolic process | 7.949893e-3 |
GO:0042167 | heme catabolic process | 7.978662e-3 |
GO:0051956 | negative regulation of amino acid transport | 8.040203e-3 |
GO:0051955 | regulation of amino acid transport | 8.050575e-3 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 8.463682e-3 |
GO:0045329 | carnitine biosynthetic process | 8.575819e-3 |
GO:0032793 | positive regulation of CREB transcription factor activity | 8.647368e-3 |
GO:0048149 | behavioral response to ethanol | 8.678771e-3 |
GO:0006189 | 'de novo' IMP biosynthetic process | 8.828636e-3 |
GO:0051953 | negative regulation of amine transport | 8.851401e-3 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 8.983590e-3 |
GO:0051220 | cytoplasmic sequestering of protein | 8.983590e-3 |
GO:0019083 | viral transcription | 9.011082e-3 |
GO:0060998 | regulation of dendritic spine development | 9.030347e-3 |
GO:0006415 | translational termination | 9.112340e-3 |
GO:0021592 | fourth ventricle development | 9.211556e-3 |
GO:0010529 | negative regulation of transposition | 9.211556e-3 |
GO:0070814 | hydrogen sulfide biosynthetic process | 9.295574e-3 |
GO:0071423 | malate transmembrane transport | 9.349443e-3 |
GO:0090324 | negative regulation of oxidative phosphorylation | 9.349443e-3 |
GO:0006844 | acyl carnitine transport | 9.349443e-3 |
GO:0015919 | peroxisomal membrane transport | 9.349443e-3 |
GO:0015709 | thiosulfate transport | 9.349443e-3 |
GO:0010255 | glucose mediated signaling pathway | 9.349443e-3 |
GO:0090072 | positive regulation of sodium ion transport via voltage-gated sodium channel activity | 9.493141e-3 |
GO:0060023 | soft palate development | 9.493141e-3 |
GO:0051584 | regulation of dopamine uptake | 9.534751e-3 |
GO:0030237 | female sex determination | 9.594499e-3 |
GO:0043501 | skeletal muscle adaptation | 9.624512e-3 |
GO:0044314 | protein K27-linked ubiquitination | 9.655168e-3 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 9.797394e-3 |
GO:0007196 | inhibition of adenylate cyclase activity by metabotropic glutamate receptor signaling pathway | 9.920568e-3 |
GO:0021759 | globus pallidus development | 9.920568e-3 |
GO:0060061 | Spemann organizer formation | 9.920956e-3 |
GO:0090150 | establishment of protein localization in membrane | 1.003449e-2 |
GO:0060923 | cardiac muscle cell fate commitment | 1.005365e-2 |
GO:0097039 | protein linear polyubiquitination | 1.005365e-2 |
GO:0001768 | establishment of T cell polarity | 1.008230e-2 |
GO:0006707 | cholesterol catabolic process | 1.012709e-2 |
GO:0001826 | inner cell mass cell differentiation | 1.016108e-2 |
GO:0015864 | pyrimidine nucleoside transport | 1.016108e-2 |
GO:0031427 | response to methotrexate | 1.021992e-2 |
GO:0060028 | convergent extension involved in axis elongation | 1.021992e-2 |
GO:0019086 | late viral mRNA transcription | 1.021992e-2 |
GO:0018206 | peptidyl-methionine modification | 1.027777e-2 |
GO:0007140 | male meiosis | 1.029476e-2 |
GO:0032984 | macromolecular complex disassembly | 1.029683e-2 |
GO:0006646 | phosphatidylethanolamine biosynthetic process | 1.032248e-2 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 1.049359e-2 |
GO:0001510 | RNA methylation | 1.050991e-2 |
GO:0006998 | nuclear envelope organization | 1.055873e-2 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 1.059518e-2 |
GO:0097107 | postsynaptic density assembly | 1.059518e-2 |
GO:0045963 | negative regulation of dopamine metabolic process | 1.059518e-2 |
GO:0050668 | positive regulation of homocysteine metabolic process | 1.059518e-2 |
GO:0007128 | meiotic prophase I | 1.086151e-2 |
GO:0051684 | maintenance of Golgi location | 1.100458e-2 |
GO:0042664 | negative regulation of endodermal cell fate specification | 1.100458e-2 |
GO:0035481 | positive regulation of Notch signaling pathway involved in heart induction | 1.100458e-2 |
GO:0060975 | cardioblast migration to the midline involved in heart field formation | 1.100458e-2 |
GO:0060921 | sinoatrial node cell differentiation | 1.100458e-2 |
GO:0003236 | sinus venosus morphogenesis | 1.100458e-2 |
GO:0003210 | cardiac atrium formation | 1.100458e-2 |
GO:0010509 | polyamine homeostasis | 1.100458e-2 |
GO:0003241 | growth involved in heart morphogenesis | 1.100458e-2 |
GO:0006427 | histidyl-tRNA aminoacylation | 1.100458e-2 |
GO:0003259 | cardioblast anterior-lateral migration | 1.100458e-2 |
GO:0000089 | mitotic metaphase | 1.114306e-2 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 1.121726e-2 |
GO:0009262 | deoxyribonucleotide metabolic process | 1.130651e-2 |
GO:0006220 | pyrimidine nucleotide metabolic process | 1.142849e-2 |
GO:0030007 | cellular potassium ion homeostasis | 1.154991e-2 |
GO:0070212 | protein poly-ADP-ribosylation | 1.154991e-2 |
GO:0035510 | DNA dealkylation | 1.165627e-2 |
GO:0032933 | SREBP-mediated signaling pathway | 1.191529e-2 |
GO:0030262 | apoptotic nuclear change | 1.207047e-2 |
GO:0051255 | spindle midzone assembly | 1.227452e-2 |
GO:0045717 | negative regulation of fatty acid biosynthetic process | 1.237775e-2 |
GO:0031017 | exocrine pancreas development | 1.262487e-2 |
GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter | 1.263313e-2 |
GO:0042711 | maternal behavior | 1.263313e-2 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 1.263313e-2 |
GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin | 1.271129e-2 |
GO:0001840 | neural plate development | 1.271129e-2 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 1.296131e-2 |
GO:0042255 | ribosome assembly | 1.299052e-2 |
GO:0010890 | positive regulation of sequestering of triglyceride | 1.300342e-2 |
GO:0021569 | rhombomere 3 development | 1.310448e-2 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 1.310448e-2 |
GO:0051292 | nuclear pore complex assembly | 1.325877e-2 |
GO:0042335 | cuticle development | 1.325877e-2 |
GO:0016486 | peptide hormone processing | 1.347268e-2 |
GO:0060377 | negative regulation of mast cell differentiation | 1.357771e-2 |
GO:0045403 | negative regulation of interleukin-4 biosynthetic process | 1.357771e-2 |
GO:0070512 | positive regulation of histone H4-K20 methylation | 1.357771e-2 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 1.357771e-2 |
GO:2000620 | positive regulation of histone H4-K16 acetylation | 1.357771e-2 |
GO:2000617 | positive regulation of histone H3-K9 acetylation | 1.357771e-2 |
GO:2000002 | negative regulation of DNA damage checkpoint | 1.357771e-2 |
GO:0003192 | mitral valve formation | 1.357771e-2 |
GO:0003106 | negative regulation of glomerular filtration by angiotensin | 1.357771e-2 |
GO:0002295 | T-helper cell lineage commitment | 1.357771e-2 |
GO:0003195 | tricuspid valve formation | 1.357771e-2 |
GO:0014895 | smooth muscle hypertrophy | 1.357771e-2 |
GO:0021551 | central nervous system morphogenesis | 1.357771e-2 |
GO:0021588 | cerebellum formation | 1.357771e-2 |
GO:0033326 | cerebrospinal fluid secretion | 1.372116e-2 |
GO:0090129 | positive regulation of synapse maturation | 1.397129e-2 |
GO:0071731 | response to nitric oxide | 1.404116e-2 |
GO:0001757 | somite specification | 1.409022e-2 |
GO:0002380 | immunoglobulin secretion involved in immune response | 1.417390e-2 |
GO:0009235 | cobalamin metabolic process | 1.417390e-2 |
GO:0050872 | white fat cell differentiation | 1.423981e-2 |
GO:0043241 | protein complex disassembly | 1.430000e-2 |
GO:0045819 | positive regulation of glycogen catabolic process | 1.440582e-2 |
GO:0045606 | positive regulation of epidermal cell differentiation | 1.473351e-2 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 1.480721e-2 |
GO:0009972 | cytidine deamination | 1.482961e-2 |
GO:0060920 | pacemaker cell differentiation | 1.486160e-2 |
GO:0052565 | response to defense-related host nitric oxide production | 1.486160e-2 |
GO:0030844 | positive regulation of intermediate filament depolymerization | 1.486160e-2 |
GO:0003175 | tricuspid valve development | 1.486160e-2 |
GO:0071474 | cellular hyperosmotic response | 1.502650e-2 |
GO:0018105 | peptidyl-serine phosphorylation | 1.506245e-2 |
GO:0061013 | regulation of mRNA catabolic process | 1.508254e-2 |
GO:0006360 | transcription from RNA polymerase I promoter | 1.512486e-2 |
GO:0032008 | positive regulation of TOR signaling cascade | 1.515469e-2 |
GO:0032922 | circadian regulation of gene expression | 1.518460e-2 |
GO:0071470 | cellular response to osmotic stress | 1.523477e-2 |
GO:0070857 | regulation of bile acid biosynthetic process | 1.529988e-2 |
GO:0003218 | cardiac left ventricle formation | 1.529988e-2 |
GO:0070489 | T cell aggregation | 1.535679e-2 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 1.553976e-2 |
GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus | 1.553976e-2 |
GO:0072144 | glomerular mesangial cell development | 1.569032e-2 |
GO:0060370 | susceptibility to T cell mediated cytotoxicity | 1.569032e-2 |
GO:0072011 | glomerular endothelium development | 1.569032e-2 |
GO:0009637 | response to blue light | 1.573790e-2 |
GO:0034260 | negative regulation of GTPase activity | 1.585866e-2 |
GO:0021658 | rhombomere 3 morphogenesis | 1.588456e-2 |
GO:0051182 | coenzyme transport | 1.588456e-2 |
GO:0006546 | glycine catabolic process | 1.593654e-2 |
GO:0015862 | uridine transport | 1.596817e-2 |
GO:0003184 | pulmonary valve morphogenesis | 1.596817e-2 |
GO:0060179 | male mating behavior | 1.597501e-2 |
GO:0045199 | maintenance of epithelial cell apical/basal polarity | 1.597501e-2 |
GO:0007063 | regulation of sister chromatid cohesion | 1.601338e-2 |
GO:0006284 | base-excision repair | 1.603961e-2 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 1.644682e-2 |
GO:0009070 | serine family amino acid biosynthetic process | 1.651787e-2 |
GO:0000712 | resolution of meiotic recombination intermediates | 1.657640e-2 |
GO:0072553 | terminal button organization | 1.696495e-2 |
GO:0034231 | islet amyloid polypeptide processing | 1.696495e-2 |
GO:0000088 | mitotic prophase | 1.696495e-2 |
GO:0034230 | enkephalin processing | 1.696495e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0050668 | positive regulation of homocysteine metabolic process | 9.993106e-7 |
GO:0045963 | negative regulation of dopamine metabolic process | 9.993106e-7 |
GO:0055015 | ventricular cardiac muscle cell development | 2.535470e-6 |
GO:0071294 | cellular response to zinc ion | 3.386559e-6 |
GO:0043973 | histone H3-K4 acetylation | 4.228854e-6 |
GO:0046985 | positive regulation of hemoglobin biosynthetic process | 4.228854e-6 |
GO:0035269 | protein O-linked mannosylation | 4.228854e-6 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 4.228854e-6 |
GO:0006829 | zinc ion transport | 4.240007e-6 |
GO:2000020 | positive regulation of male gonad development | 6.673759e-6 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 1.584391e-5 |
GO:0035307 | positive regulation of protein dephosphorylation | 2.235522e-5 |
GO:0000183 | chromatin silencing at rDNA | 2.334561e-5 |
GO:0090161 | Golgi ribbon formation | 2.415763e-5 |
GO:0030035 | microspike assembly | 2.761058e-5 |
GO:0061034 | olfactory bulb mitral cell layer development | 2.842038e-5 |
GO:0035306 | positive regulation of dephosphorylation | 3.318695e-5 |
GO:0070316 | regulation of G0 to G1 transition | 3.399904e-5 |
GO:0046847 | filopodium assembly | 3.575974e-5 |
GO:2000195 | negative regulation of female gonad development | 5.229123e-5 |
GO:0021526 | medial motor column neuron differentiation | 5.347379e-5 |
GO:0071422 | succinate transmembrane transport | 5.347379e-5 |
GO:0046580 | negative regulation of Ras protein signal transduction | 5.422592e-5 |
GO:2000018 | regulation of male gonad development | 5.572383e-5 |
GO:0016925 | protein sumoylation | 5.623617e-5 |
GO:0006383 | transcription from RNA polymerase III promoter | 5.706498e-5 |
GO:0021696 | cerebellar cortex morphogenesis | 7.341940e-5 |
GO:0048672 | positive regulation of collateral sprouting | 8.248710e-5 |
GO:0021819 | layer formation in cerebral cortex | 8.251215e-5 |
GO:0021527 | spinal cord association neuron differentiation | 8.383226e-5 |
GO:0048665 | neuron fate specification | 9.139195e-5 |
GO:0070179 | D-serine biosynthetic process | 9.998660e-5 |
GO:0035674 | tricarboxylic acid transmembrane transport | 9.998660e-5 |
GO:0014028 | notochord formation | 9.998660e-5 |
GO:0046984 | regulation of hemoglobin biosynthetic process | 1.001283e-4 |
GO:0046416 | D-amino acid metabolic process | 1.191805e-4 |
GO:0051586 | positive regulation of dopamine uptake | 1.447431e-4 |
GO:0051058 | negative regulation of small GTPase mediated signal transduction | 1.565917e-4 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.687811e-4 |
GO:0021695 | cerebellar cortex development | 1.691995e-4 |
GO:0003221 | right ventricular cardiac muscle tissue morphogenesis | 2.010220e-4 |
GO:0006011 | UDP-glucose metabolic process | 2.016877e-4 |
GO:0035520 | monoubiquitinated protein deubiquitination | 2.016877e-4 |
GO:0021511 | spinal cord patterning | 2.330415e-4 |
GO:0018205 | peptidyl-lysine modification | 2.407067e-4 |
GO:0021513 | spinal cord dorsal/ventral patterning | 2.430810e-4 |
GO:0035024 | negative regulation of Rho protein signal transduction | 2.437699e-4 |
GO:0015876 | acetyl-CoA transport | 2.511731e-4 |
GO:0006342 | chromatin silencing | 2.529235e-4 |
GO:0035444 | nickel ion transmembrane transport | 2.607722e-4 |
GO:0070278 | extracellular matrix constituent secretion | 2.636115e-4 |
GO:0010260 | organ senescence | 2.636115e-4 |
GO:0002098 | tRNA wobble uridine modification | 2.749667e-4 |
GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.970552e-4 |
GO:0060452 | positive regulation of cardiac muscle contraction | 2.970552e-4 |
GO:0051176 | positive regulation of sulfur metabolic process | 3.216518e-4 |
GO:0034227 | tRNA thio-modification | 3.817561e-4 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 3.817561e-4 |
GO:0032312 | regulation of ARF GTPase activity | 3.909787e-4 |
GO:2000194 | regulation of female gonad development | 3.930340e-4 |
GO:0021871 | forebrain regionalization | 4.107554e-4 |
GO:0055014 | atrial cardiac muscle cell development | 4.396171e-4 |
GO:0045647 | negative regulation of erythrocyte differentiation | 4.700188e-4 |
GO:0090083 | regulation of inclusion body assembly | 4.821897e-4 |
GO:0035855 | megakaryocyte development | 4.821897e-4 |
GO:0006474 | N-terminal protein amino acid acetylation | 4.924490e-4 |
GO:0070318 | positive regulation of G0 to G1 transition | 5.037032e-4 |
GO:0021514 | ventral spinal cord interneuron differentiation | 5.270274e-4 |
GO:0070831 | basement membrane assembly | 5.780599e-4 |
GO:0019255 | glucose 1-phosphate metabolic process | 5.906008e-4 |
GO:0019101 | female somatic sex determination | 6.309555e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 6.309555e-4 |
GO:0042703 | menstruation | 6.309555e-4 |
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 6.309555e-4 |
GO:0006258 | UDP-glucose catabolic process | 6.309555e-4 |
GO:0018293 | protein-FAD linkage | 6.309555e-4 |
GO:0060579 | ventral spinal cord interneuron fate commitment | 6.476981e-4 |
GO:0001825 | blastocyst formation | 6.648465e-4 |
GO:0021797 | forebrain anterior/posterior pattern specification | 6.656963e-4 |
GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | 7.018326e-4 |
GO:0043314 | negative regulation of neutrophil degranulation | 7.808992e-4 |
GO:0035802 | adrenal cortex formation | 7.948504e-4 |
GO:0002074 | extraocular skeletal muscle development | 7.948504e-4 |
GO:0042273 | ribosomal large subunit biogenesis | 8.019034e-4 |
GO:0046102 | inosine metabolic process | 8.894790e-4 |
GO:0016573 | histone acetylation | 9.422816e-4 |
GO:0007140 | male meiosis | 9.594259e-4 |
GO:0010735 | positive regulation of transcription via serum response element binding | 9.614174e-4 |
GO:0060896 | neural plate pattern specification | 9.799109e-4 |
GO:0035507 | regulation of myosin-light-chain-phosphatase activity | 1.018121e-3 |
GO:0030851 | granulocyte differentiation | 1.035966e-3 |
GO:0031507 | heterochromatin formation | 1.060482e-3 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 1.109625e-3 |
GO:0030431 | sleep | 1.184940e-3 |
GO:0015670 | carbon dioxide transport | 1.195536e-3 |
GO:0033239 | negative regulation of cellular amine metabolic process | 1.242820e-3 |
GO:0001829 | trophectodermal cell differentiation | 1.258818e-3 |
GO:0014909 | smooth muscle cell migration | 1.281764e-3 |
GO:0042428 | serotonin metabolic process | 1.466389e-3 |
GO:0071577 | zinc ion transmembrane transport | 1.481818e-3 |
GO:0032119 | sequestering of zinc ion | 1.540840e-3 |
GO:0006409 | tRNA export from nucleus | 1.584961e-3 |
GO:0071169 | establishment of protein localization to chromatin | 1.584961e-3 |
GO:0031468 | nuclear envelope reassembly | 1.584961e-3 |
GO:0040040 | thermosensory behavior | 1.611851e-3 |
GO:0002730 | regulation of dendritic cell cytokine production | 1.611851e-3 |
GO:0032319 | regulation of Rho GTPase activity | 1.613900e-3 |
GO:0019673 | GDP-mannose metabolic process | 1.645559e-3 |
GO:0051443 | positive regulation of ubiquitin-protein ligase activity | 1.655260e-3 |
GO:0030219 | megakaryocyte differentiation | 1.659229e-3 |
GO:0021521 | ventral spinal cord interneuron specification | 1.694069e-3 |
GO:0009435 | NAD biosynthetic process | 1.731742e-3 |
GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 1.835854e-3 |
GO:0097107 | postsynaptic density assembly | 1.835854e-3 |
GO:0031914 | negative regulation of synaptic plasticity | 1.835854e-3 |
GO:0070845 | polyubiquitinated misfolded protein transport | 1.835854e-3 |
GO:0048384 | retinoic acid receptor signaling pathway | 1.847341e-3 |
GO:0010950 | positive regulation of endopeptidase activity | 1.866293e-3 |
GO:0071715 | icosanoid transport | 1.874354e-3 |
GO:0060033 | anatomical structure regression | 1.910299e-3 |
GO:0045908 | negative regulation of vasodilation | 1.911964e-3 |
GO:0030903 | notochord development | 1.936181e-3 |
GO:0060124 | positive regulation of growth hormone secretion | 1.968233e-3 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 1.985239e-3 |
GO:0021697 | cerebellar cortex formation | 2.007510e-3 |
GO:0050685 | positive regulation of mRNA processing | 2.024195e-3 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 2.072863e-3 |
GO:0021515 | cell differentiation in spinal cord | 2.124936e-3 |
GO:0043300 | regulation of leukocyte degranulation | 2.225941e-3 |
GO:0030902 | hindbrain development | 2.302367e-3 |
GO:0033158 | regulation of protein import into nucleus, translocation | 2.302706e-3 |
GO:0032774 | RNA biosynthetic process | 2.358491e-3 |
GO:0006601 | creatine biosynthetic process | 2.396398e-3 |
GO:0010544 | negative regulation of platelet activation | 2.499162e-3 |
GO:0046717 | acid secretion | 2.525320e-3 |
GO:0030046 | parallel actin filament bundle assembly | 2.668934e-3 |
GO:0042694 | muscle cell fate specification | 2.668934e-3 |
GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway | 2.694291e-3 |
GO:0021587 | cerebellum morphogenesis | 2.766016e-3 |
GO:0032784 | regulation of transcription elongation, DNA-dependent | 2.772369e-3 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 2.898044e-3 |
GO:0045112 | integrin biosynthetic process | 2.910084e-3 |
GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation | 2.910084e-3 |
GO:0042866 | pyruvate biosynthetic process | 2.910084e-3 |
GO:0015747 | urate transport | 2.916217e-3 |
GO:0008612 | peptidyl-lysine modification to hypusine | 2.916217e-3 |
GO:0007143 | female meiosis | 2.977467e-3 |
GO:0060319 | primitive erythrocyte differentiation | 3.085430e-3 |
GO:0042053 | regulation of dopamine metabolic process | 3.086493e-3 |
GO:0030031 | cell projection assembly | 3.155171e-3 |
GO:0006351 | transcription, DNA-dependent | 3.175968e-3 |
GO:0018394 | peptidyl-lysine acetylation | 3.177114e-3 |
GO:2000772 | regulation of cellular senescence | 3.310945e-3 |
GO:0006473 | protein acetylation | 3.339276e-3 |
GO:0030970 | retrograde protein transport, ER to cytosol | 3.364034e-3 |
GO:0018393 | internal peptidyl-lysine acetylation | 3.401422e-3 |
GO:0021549 | cerebellum development | 3.481749e-3 |
GO:0045454 | cell redox homeostasis | 3.563828e-3 |
GO:0071340 | skeletal muscle nicotinic acetylcholine receptor clustering | 3.669215e-3 |
GO:0035611 | protein branching point deglutamylation | 3.669215e-3 |
GO:0048663 | neuron fate commitment | 3.727215e-3 |
GO:0018364 | peptidyl-glutamine methylation | 3.737723e-3 |
GO:0046103 | inosine biosynthetic process | 3.737723e-3 |
GO:0006154 | adenosine catabolic process | 3.737723e-3 |
GO:0048227 | plasma membrane to endosome transport | 3.981374e-3 |
GO:0021528 | commissural neuron differentiation in spinal cord | 3.981374e-3 |
GO:0021516 | dorsal spinal cord development | 4.306356e-3 |
GO:0045162 | clustering of voltage-gated sodium channels | 4.346827e-3 |
GO:0019348 | dolichol metabolic process | 4.346827e-3 |
GO:0001840 | neural plate development | 4.454716e-3 |
GO:0042136 | neurotransmitter biosynthetic process | 4.464516e-3 |
GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 4.464516e-3 |
GO:0034453 | microtubule anchoring | 4.477718e-3 |
GO:0090084 | negative regulation of inclusion body assembly | 4.558234e-3 |
GO:2000383 | regulation of ectoderm development | 4.558234e-3 |
GO:0043543 | protein acylation | 4.563644e-3 |
GO:0006290 | pyrimidine dimer repair | 4.825750e-3 |
GO:0007352 | zygotic specification of dorsal/ventral axis | 4.916645e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 4.946513e-3 |
GO:0042420 | dopamine catabolic process | 4.961818e-3 |
GO:0048840 | otolith development | 4.977790e-3 |
GO:0042069 | regulation of catecholamine metabolic process | 5.280366e-3 |
GO:0051567 | histone H3-K9 methylation | 5.307952e-3 |
GO:0034059 | response to anoxia | 5.480393e-3 |
GO:0048670 | regulation of collateral sprouting | 5.499090e-3 |
GO:0016068 | type I hypersensitivity | 5.706935e-3 |
GO:0035621 | ER to Golgi ceramide transport | 5.706935e-3 |
GO:0009798 | axis specification | 5.711670e-3 |
GO:0072224 | metanephric glomerulus development | 5.984818e-3 |
GO:0021575 | hindbrain morphogenesis | 6.034701e-3 |
GO:0050891 | multicellular organismal water homeostasis | 6.081212e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 6.150168e-3 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 6.150168e-3 |
GO:0018065 | protein-cofactor linkage | 6.150168e-3 |
GO:0007356 | thorax and anterior abdomen determination | 6.150168e-3 |
GO:0090218 | positive regulation of lipid kinase activity | 6.563241e-3 |
GO:0035928 | rRNA import into mitochondrion | 6.691318e-3 |
GO:0006668 | sphinganine-1-phosphate metabolic process | 6.691318e-3 |
GO:0002481 | antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent | 6.691318e-3 |
GO:0048570 | notochord morphogenesis | 6.862669e-3 |
GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway | 7.115672e-3 |
GO:0009452 | RNA capping | 7.223038e-3 |
GO:0032571 | response to vitamin K | 7.436684e-3 |
GO:2001037 | positive regulation of tongue muscle cell differentiation | 7.436684e-3 |
GO:2000384 | negative regulation of ectoderm development | 7.436684e-3 |
GO:0018993 | somatic sex determination | 7.491491e-3 |
GO:0008611 | ether lipid biosynthetic process | 7.491491e-3 |
GO:0043457 | regulation of cellular respiration | 7.787230e-3 |
GO:0072166 | posterior mesonephric tubule development | 7.821569e-3 |
GO:0060978 | angiogenesis involved in coronary vascular morphogenesis | 7.821569e-3 |
GO:0051238 | sequestering of metal ion | 7.873304e-3 |
GO:0023021 | termination of signal transduction | 7.873304e-3 |
GO:0007216 | metabotropic glutamate receptor signaling pathway | 7.927011e-3 |
GO:0021794 | thalamus development | 8.171295e-3 |
GO:0042998 | positive regulation of Golgi to plasma membrane protein transport | 8.263002e-3 |
GO:0060928 | atrioventricular node cell development | 8.263002e-3 |
GO:0060929 | atrioventricular node cell fate commitment | 8.263002e-3 |
GO:0031119 | tRNA pseudouridine synthesis | 8.263002e-3 |
GO:0032782 | bile acid secretion | 8.263002e-3 |
GO:0017196 | N-terminal peptidyl-methionine acetylation | 8.263002e-3 |
GO:0003342 | proepicardium development | 8.263002e-3 |
GO:0003168 | cardiac Purkinje fiber cell differentiation | 8.263002e-3 |
GO:0003096 | renal sodium ion transport | 8.263002e-3 |
GO:0015761 | mannose transport | 8.263002e-3 |
GO:0006837 | serotonin transport | 8.370684e-3 |
GO:0050482 | arachidonic acid secretion | 8.405538e-3 |
GO:0070309 | lens fiber cell morphogenesis | 8.743304e-3 |
GO:0015746 | citrate transport | 8.967865e-3 |
GO:0007614 | short-term memory | 9.217850e-3 |
GO:0022037 | metencephalon development | 9.644294e-3 |
GO:0072015 | glomerular visceral epithelial cell development | 9.857285e-3 |
GO:0032515 | negative regulation of phosphoprotein phosphatase activity | 9.857285e-3 |
GO:0015696 | ammonium transport | 9.950588e-3 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 1.000096e-2 |
GO:0051684 | maintenance of Golgi location | 1.000096e-2 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 1.000096e-2 |
GO:2000119 | negative regulation of sodium-dependent phosphate transport | 1.000096e-2 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 1.000096e-2 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 1.000096e-2 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 1.000096e-2 |
GO:0019676 | ammonia assimilation cycle | 1.000096e-2 |
GO:0002368 | B cell cytokine production | 1.000096e-2 |
GO:0032707 | negative regulation of interleukin-23 production | 1.000096e-2 |
GO:0042450 | arginine biosynthetic process via ornithine | 1.000096e-2 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 1.000096e-2 |
GO:0048291 | isotype switching to IgG isotypes | 1.000096e-2 |
GO:0007144 | female meiosis I | 1.014357e-2 |
GO:0001678 | cellular glucose homeostasis | 1.027945e-2 |
GO:0034447 | very-low-density lipoprotein particle clearance | 1.038359e-2 |
GO:0090224 | regulation of spindle organization | 1.052144e-2 |
GO:0006403 | RNA localization | 1.069355e-2 |
GO:0048339 | paraxial mesoderm development | 1.082552e-2 |
GO:0048671 | negative regulation of collateral sprouting | 1.084827e-2 |
GO:0060123 | regulation of growth hormone secretion | 1.102284e-2 |
GO:0021702 | cerebellar Purkinje cell differentiation | 1.124839e-2 |
GO:0071157 | negative regulation of cell cycle arrest | 1.129609e-2 |
GO:0043302 | positive regulation of leukocyte degranulation | 1.140192e-2 |
GO:0032012 | regulation of ARF protein signal transduction | 1.141599e-2 |
GO:0042424 | catecholamine catabolic process | 1.147507e-2 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 1.147507e-2 |
GO:0001831 | trophectodermal cellular morphogenesis | 1.147507e-2 |
GO:0071394 | cellular response to testosterone stimulus | 1.172243e-2 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 1.174361e-2 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 1.180766e-2 |
GO:0070368 | positive regulation of hepatocyte differentiation | 1.189867e-2 |
GO:0006475 | internal protein amino acid acetylation | 1.191020e-2 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 1.195776e-2 |
GO:0003091 | renal water homeostasis | 1.214079e-2 |
GO:0021997 | neural plate axis specification | 1.219898e-2 |
GO:0032855 | positive regulation of Rac GTPase activity | 1.253762e-2 |
GO:0060948 | cardiac vascular smooth muscle cell development | 1.263527e-2 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 1.263527e-2 |
GO:0045814 | negative regulation of gene expression, epigenetic | 1.265970e-2 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 1.273236e-2 |
GO:0060729 | intestinal epithelial structure maintenance | 1.275614e-2 |
GO:0007418 | ventral midline development | 1.275614e-2 |
GO:0021681 | cerebellar granular layer development | 1.315284e-2 |
GO:0055012 | ventricular cardiac muscle cell differentiation | 1.318447e-2 |
GO:0051351 | positive regulation of ligase activity | 1.367024e-2 |
GO:0048340 | paraxial mesoderm morphogenesis | 1.409282e-2 |
GO:0043304 | regulation of mast cell degranulation | 1.434531e-2 |
GO:0048368 | lateral mesoderm development | 1.438582e-2 |
GO:0032792 | negative regulation of CREB transcription factor activity | 1.446826e-2 |
GO:0001778 | plasma membrane repair | 1.446826e-2 |
GO:0006405 | RNA export from nucleus | 1.468534e-2 |
GO:0060163 | subpallium neuron fate commitment | 1.474487e-2 |
GO:0060217 | hemangioblast cell differentiation | 1.474487e-2 |
GO:0090035 | positive regulation of cellular chaperone-mediated protein complex assembly | 1.474487e-2 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 1.474487e-2 |
GO:2000016 | negative regulation of determination of dorsal identity | 1.474487e-2 |
GO:0006408 | snRNA export from nucleus | 1.474487e-2 |
GO:0000073 | spindle pole body separation | 1.474487e-2 |
GO:0045799 | positive regulation of chromatin assembly or disassembly | 1.474487e-2 |
GO:0022417 | protein maturation by protein folding | 1.474487e-2 |
GO:0045299 | otolith mineralization | 1.474487e-2 |
GO:0010447 | response to acidity | 1.494362e-2 |
GO:0060911 | cardiac cell fate commitment | 1.517469e-2 |
GO:0031365 | N-terminal protein amino acid modification | 1.533315e-2 |
GO:0010669 | epithelial structure maintenance | 1.576470e-2 |
GO:0006884 | cell volume homeostasis | 1.581944e-2 |
GO:0033006 | regulation of mast cell activation involved in immune response | 1.628879e-2 |
GO:0060215 | primitive hemopoiesis | 1.634056e-2 |
GO:0007616 | long-term memory | 1.664769e-2 |
GO:0032836 | glomerular basement membrane development | 1.665246e-2 |
GO:0072239 | metanephric glomerulus vasculature development | 1.665741e-2 |
GO:0051313 | attachment of spindle microtubules to chromosome | 1.665741e-2 |
GO:0060923 | cardiac muscle cell fate commitment | 1.669301e-2 |
GO:0060971 | embryonic heart tube left/right pattern formation | 1.687591e-2 |
GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 1.687591e-2 |
GO:0016191 | synaptic vesicle uncoating | 1.687591e-2 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 1.687591e-2 |
GO:0043306 | positive regulation of mast cell degranulation | 1.690943e-2 |
GO:0048251 | elastic fiber assembly | 1.717247e-2 |
GO:0060177 | regulation of angiotensin metabolic process | 1.722207e-2 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 1.741367e-2 |
GO:0043313 | regulation of neutrophil degranulation | 1.741367e-2 |
GO:0015879 | carnitine transport | 1.778341e-2 |
GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation | 1.818008e-2 |
GO:2000774 | positive regulation of cellular senescence | 1.819913e-2 |
GO:0090402 | oncogene-induced senescence | 1.819913e-2 |
GO:0035986 | senescence-associated heterochromatin focus formation | 1.819913e-2 |
GO:0035810 | positive regulation of urine volume | 1.819913e-2 |
GO:0001880 | Mullerian duct regression | 1.832961e-2 |
GO:0032853 | positive regulation of Ran GTPase activity | 1.835985e-2 |
GO:0030322 | stabilization of membrane potential | 1.835985e-2 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 1.835985e-2 |
GO:0072104 | glomerular capillary formation | 1.836274e-2 |
GO:0015692 | lead ion transport | 1.841222e-2 |
GO:0070627 | ferrous iron import | 1.841222e-2 |
GO:0015676 | vanadium ion transport | 1.841222e-2 |
GO:0010312 | detoxification of zinc ion | 1.841222e-2 |
GO:0045880 | positive regulation of smoothened signaling pathway | 1.844742e-2 |
GO:0051865 | protein autoubiquitination | 1.874797e-2 |
GO:0003002 | regionalization | 1.882298e-2 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 1.924898e-2 |
GO:0050772 | positive regulation of axonogenesis | 1.929561e-2 |
GO:0006824 | cobalt ion transport | 1.944308e-2 |
GO:0006669 | sphinganine-1-phosphate biosynthetic process | 1.946993e-2 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 1.985779e-2 |
GO:0060024 | rhythmic synaptic transmission | 1.985779e-2 |
GO:0030221 | basophil differentiation | 2.014796e-2 |
GO:0021508 | floor plate formation | 2.014796e-2 |
GO:0006189 | 'de novo' IMP biosynthetic process | 2.014796e-2 |
GO:0015824 | proline transport | 2.019782e-2 |
GO:0014047 | glutamate secretion | 2.019782e-2 |
GO:0016572 | histone phosphorylation | 2.024949e-2 |
GO:0060561 | apoptosis involved in morphogenesis | 2.039129e-2 |
GO:0032926 | negative regulation of activin receptor signaling pathway | 2.045019e-2 |
GO:0042747 | circadian sleep/wake cycle, REM sleep | 2.052689e-2 |
GO:0019388 | galactose catabolic process | 2.052689e-2 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 2.058339e-2 |
GO:0045905 | positive regulation of translational termination | 2.063203e-2 |
GO:0045901 | positive regulation of translational elongation | 2.063203e-2 |
GO:0051639 | actin filament network formation | 2.063203e-2 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 2.063203e-2 |
GO:0030505 | inorganic diphosphate transport | 2.063203e-2 |
GO:0006452 | translational frameshifting | 2.063203e-2 |
GO:0034653 | retinoic acid catabolic process | 2.063203e-2 |
GO:2000381 | negative regulation of mesoderm development | 2.067116e-2 |
GO:0065001 | specification of axis polarity | 2.067116e-2 |
GO:0010991 | negative regulation of SMAD protein complex assembly | 2.067116e-2 |
GO:0030837 | negative regulation of actin filament polymerization | 2.072141e-2 |
GO:0035886 | vascular smooth muscle cell differentiation | 2.157125e-2 |
GO:0045657 | positive regulation of monocyte differentiation | 2.163074e-2 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 2.167856e-2 |
GO:0070293 | renal absorption | 2.221275e-2 |
GO:0072125 | negative regulation of glomerular mesangial cell proliferation | 2.255754e-2 |
GO:0033120 | positive regulation of RNA splicing | 2.259051e-2 |
GO:0021510 | spinal cord development | 2.266035e-2 |
GO:0014056 | regulation of acetylcholine secretion | 2.350872e-2 |
GO:0061104 | adrenal chromaffin cell differentiation | 2.434126e-2 |
GO:0061103 | carotid body glomus cell differentiation | 2.434126e-2 |
GO:0071247 | cellular response to chromate | 2.434126e-2 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 2.434126e-2 |
GO:0061102 | stomach neuroendocrine cell differentiation | 2.434126e-2 |
GO:0071259 | cellular response to magnetism | 2.434126e-2 |
GO:0003359 | noradrenergic neuron fate commitment | 2.434126e-2 |
GO:0007400 | neuroblast fate determination | 2.434126e-2 |
GO:0000059 | protein import into nucleus, docking | 2.434126e-2 |
GO:0034259 | negative regulation of Rho GTPase activity | 2.434126e-2 |
GO:0048697 | positive regulation of collateral sprouting in absence of injury | 2.434126e-2 |
GO:0060165 | regulation of timing of subpallium neuron differentiation | 2.434126e-2 |
GO:0061100 | lung neuroendocrine cell differentiation | 2.434126e-2 |
GO:0032849 | positive regulation of cellular pH reduction | 2.448145e-2 |
GO:0085029 | extracellular matrix assembly | 2.467963e-2 |
GO:0021683 | cerebellar granular layer morphogenesis | 2.508679e-2 |
GO:0080164 | regulation of nitric oxide metabolic process | 2.512144e-2 |
GO:0070317 | negative regulation of G0 to G1 transition | 2.512144e-2 |
GO:0035502 | metanephric ureteric bud development | 2.512144e-2 |
GO:0060035 | notochord cell development | 2.512144e-2 |
GO:0006882 | cellular zinc ion homeostasis | 2.537424e-2 |
GO:2000210 | positive regulation of anoikis | 2.547187e-2 |
GO:0072112 | glomerular visceral epithelial cell differentiation | 2.627671e-2 |
GO:0060359 | response to ammonium ion | 2.647480e-2 |
GO:0021612 | facial nerve structural organization | 2.748343e-2 |
GO:0048026 | positive regulation of nuclear mRNA splicing, via spliceosome | 2.813234e-2 |
GO:0071333 | cellular response to glucose stimulus | 2.814998e-2 |
GO:0033566 | gamma-tubulin complex localization | 2.840995e-2 |
GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase | 2.840995e-2 |
GO:0034048 | negative regulation of protein phosphatase type 2A activity | 2.840995e-2 |
GO:0006235 | dTTP biosynthetic process | 2.840995e-2 |
GO:0010966 | regulation of phosphate transport | 2.840995e-2 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 2.840995e-2 |
GO:0032416 | negative regulation of sodium:hydrogen antiporter activity | 2.840995e-2 |
GO:0070574 | cadmium ion transmembrane transport | 2.848880e-2 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 2.848880e-2 |
GO:0035313 | wound healing, spreading of epidermal cells | 2.877688e-2 |
GO:0033083 | regulation of immature T cell proliferation | 2.908229e-2 |
GO:0021546 | rhombomere development | 2.908229e-2 |
GO:0009649 | entrainment of circadian clock | 2.912371e-2 |
GO:0032481 | positive regulation of type I interferon production | 2.926533e-2 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 2.943509e-2 |
GO:0000072 | M phase specific microtubule process | 2.947926e-2 |
GO:0055075 | potassium ion homeostasis | 2.948085e-2 |
GO:0007097 | nuclear migration | 2.989652e-2 |
GO:0021517 | ventral spinal cord development | 3.005197e-2 |
GO:0051303 | establishment of chromosome localization | 3.034442e-2 |
GO:0031584 | activation of phospholipase D activity | 3.043962e-2 |
GO:0042363 | fat-soluble vitamin catabolic process | 3.043962e-2 |
GO:0034587 | piRNA metabolic process | 3.060216e-2 |
GO:0001820 | serotonin secretion | 3.061349e-2 |
GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 3.064946e-2 |
GO:0043276 | anoikis | 3.088729e-2 |
GO:0021569 | rhombomere 3 development | 3.088729e-2 |
GO:0001955 | blood vessel maturation | 3.088729e-2 |
GO:0042360 | vitamin E metabolic process | 3.106497e-2 |
GO:0031129 | inductive cell-cell signaling | 3.106497e-2 |
GO:0007264 | small GTPase mediated signal transduction | 3.107628e-2 |
GO:0006449 | regulation of translational termination | 3.135010e-2 |
GO:0005981 | regulation of glycogen catabolic process | 3.146950e-2 |
GO:0055069 | zinc ion homeostasis | 3.189796e-2 |
GO:0006415 | translational termination | 3.235235e-2 |
GO:0035912 | dorsal aorta morphogenesis | 3.269200e-2 |
GO:0034421 | post-translational protein acetylation | 3.269200e-2 |
GO:0046952 | ketone body catabolic process | 3.269200e-2 |
GO:0046940 | nucleoside monophosphate phosphorylation | 3.269200e-2 |
GO:0033572 | transferrin transport | 3.269200e-2 |
GO:0008216 | spermidine metabolic process | 3.269200e-2 |
GO:0021979 | hypothalamus cell differentiation | 3.269200e-2 |
GO:0030038 | contractile actin filament bundle assembly | 3.269200e-2 |
GO:0090234 | regulation of kinetochore assembly | 3.291018e-2 |
GO:0090169 | regulation of spindle assembly | 3.291018e-2 |
GO:2000124 | regulation of endocannabinoid signaling pathway | 3.291018e-2 |
GO:0022616 | DNA strand elongation | 3.291018e-2 |
GO:0003056 | regulation of vascular smooth muscle contraction | 3.291018e-2 |
GO:0051292 | nuclear pore complex assembly | 3.348141e-2 |
GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development | 3.348141e-2 |
GO:0006438 | valyl-tRNA aminoacylation | 3.348141e-2 |
GO:0032933 | SREBP-mediated signaling pathway | 3.355352e-2 |
GO:0021523 | somatic motor neuron differentiation | 3.355352e-2 |
GO:0015891 | siderophore transport | 3.357140e-2 |
GO:0000415 | negative regulation of histone H3-K36 methylation | 3.357140e-2 |
GO:0001830 | trophectodermal cell fate commitment | 3.357140e-2 |
GO:0043923 | positive regulation by host of viral transcription | 3.359909e-2 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 3.363239e-2 |
GO:0060032 | notochord regression | 3.383944e-2 |
GO:0032613 | interleukin-10 production | 3.383944e-2 |
GO:0045906 | negative regulation of vasoconstriction | 3.387624e-2 |
GO:0035793 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | 3.387624e-2 |
GO:0015937 | coenzyme A biosynthetic process | 3.390002e-2 |
GO:0034498 | early endosome to Golgi transport | 3.390512e-2 |
GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway | 3.390512e-2 |
GO:0021530 | spinal cord oligodendrocyte cell fate specification | 3.390512e-2 |
GO:0009953 | dorsal/ventral pattern formation | 3.397682e-2 |
GO:0072488 | ammonium transmembrane transport | 3.545847e-2 |
GO:0009264 | deoxyribonucleotide catabolic process | 3.545847e-2 |
GO:0042733 | embryonic digit morphogenesis | 3.627837e-2 |
GO:0043624 | cellular protein complex disassembly | 3.638947e-2 |
GO:0010665 | regulation of cardiac muscle cell apoptosis | 3.692693e-2 |
GO:0070584 | mitochondrion morphogenesis | 3.739984e-2 |
GO:0006364 | rRNA processing | 3.747501e-2 |
GO:0021707 | cerebellar granule cell differentiation | 3.757792e-2 |
GO:0035176 | social behavior | 3.759008e-2 |
GO:0001824 | blastocyst development | 3.795818e-2 |
GO:0043967 | histone H4 acetylation | 3.869058e-2 |
GO:2000015 | regulation of determination of dorsal identity | 3.879108e-2 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 3.879108e-2 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 3.919402e-2 |
GO:0009113 | purine base biosynthetic process | 3.932515e-2 |
GO:0007182 | common-partner SMAD protein phosphorylation | 3.957427e-2 |
GO:0042942 | D-serine transport | 4.009888e-2 |
GO:0034725 | DNA replication-dependent nucleosome disassembly | 4.009888e-2 |
GO:0051160 | L-xylitol catabolic process | 4.009888e-2 |
GO:0071352 | cellular response to interleukin-2 | 4.009888e-2 |
GO:0046604 | positive regulation of mitotic centrosome separation | 4.009888e-2 |
GO:0046370 | fructose biosynthetic process | 4.009888e-2 |
GO:0034276 | kynurenic acid biosynthetic process | 4.009888e-2 |
GO:0000027 | ribosomal large subunit assembly | 4.009888e-2 |
GO:0002534 | cytokine production involved in inflammatory response | 4.009888e-2 |
GO:0002357 | defense response to tumor cell | 4.009888e-2 |
GO:0021941 | negative regulation of cerebellar granule cell precursor proliferation | 4.009888e-2 |
GO:0006062 | sorbitol catabolic process | 4.009888e-2 |
GO:0060026 | convergent extension | 4.046004e-2 |
GO:0031333 | negative regulation of protein complex assembly | 4.122744e-2 |
GO:0043586 | tongue development | 4.134537e-2 |
GO:0055089 | fatty acid homeostasis | 4.135120e-2 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4.168434e-2 |
GO:0006999 | nuclear pore organization | 4.168434e-2 |
GO:0002524 | hypersensitivity | 4.168434e-2 |
GO:0045862 | positive regulation of proteolysis | 4.176391e-2 |